Ding Zhang Selected Research

laurocapram (Azone)

11/2021	Topical delivery of gambogic acid assisted by the combination of low-frequency ultrasound and chemical enhancers for chemotherapy of cutaneous melanoma.
1/2021	New Delivery Route of Gambogic Acid Via Skin for Topical Targeted Therapy of Cutaneous Melanoma and Reduction of Systemic Toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ding Zhang Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 10/2012
7	Infections 01/2022 - 01/2012
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
4	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 05/2021 - 09/2014
4	Inflammation (Inflammations) 12/2020 - 01/2012
3	Melanoma (Melanoma, Malignant) 11/2021 - 10/2012
3	Microsatellite Instability 08/2021 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 09/2017 - 01/2012
2	Cholangiocarcinoma 05/2022 - 01/2021
2	Osteoporosis 01/2022 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 12/2020
2	Fibrosis (Cirrhosis) 02/2020 - 01/2012
2	Necrosis 01/2017 - 01/2015
2	Carcinoma (Carcinomatosis) 06/2016 - 01/2015
2	Lung Neoplasms (Lung Cancer) 06/2015 - 11/2014
2	Chronic Hepatitis B 09/2014 - 01/2012
1	Unilateral Breast Neoplasms 01/2022
1	Postoperative Pain 01/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2022
1	Emergence Delirium 01/2022
1	Cerebral Infarction 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Edema (Dropsy) 12/2020
1	Acute Lung Injury 12/2020
1	Granuloma 02/2020
1	Trigeminal Neuralgia (Tic Douloureux) 02/2020
1	Hepatitis 01/2020
1	Multiple Myeloma 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Neck Pain (Cervicalgia) 01/2019
1	Telangiectasis (Telangiectasia) 01/2019
1	Spondylosis 01/2019

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2012
6	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 06/2015
6	CytokinesIBA 01/2021 - 09/2010
5	Messenger RNA (mRNA)IBA 01/2021 - 01/2014
2	GlucocorticoidsIBA 01/2022 - 01/2020
2	gambogic acidIBA 11/2021 - 01/2021
2	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 11/2021 - 01/2021
2	laurocapram (Azone)IBA 11/2021 - 01/2021
2	Thiram FDA Link 05/2021 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
2	atezolizumabIBA 01/2021 - 01/2021
2	AgarIBA 12/2017 - 09/2017
1	VemurafenibIBA 05/2022
1	cemiplimabIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Teriparatide (Parathar)FDA Link 01/2022
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2022
1	Cetuximab (Erbitux)FDA Link 08/2021
1	Bevacizumab (Avastin)FDA Link 08/2021
1	Janus KinasesIBA 05/2021
1	Competitive Endogenous RNAIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	AfatinibIBA 01/2021
1	ChemokinesIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	ras ProteinsIBA 10/2020
1	NucleotidesIBA 10/2020
1	Growth Factor ReceptorsIBA 01/2020
1	LigandsIBA 01/2020
1	AutoantibodiesIBA 01/2020
1	Aspartic Acid (Aspartate)FDA Link 01/2020
1	CateninsIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	NivolumabIBA 01/2020
1	Cyclin D1IBA 01/2019
1	EndoglinIBA 01/2019
1	CyclinsIBA 01/2019

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2012
5	Drug Therapy (Chemotherapy) 05/2022 - 02/2018
3	Immunotherapy 08/2021 - 06/2015
2	Radiotherapy 01/2022 - 12/2021
2	Intravenous Injections 11/2021 - 01/2021
2	Lasers (Laser) 06/2016 - 10/2012
2	Photothermal Therapy 06/2016 - 10/2012
1	Moxibustion 01/2022
1	Activities of Daily Living (ADL) 01/2022
1	Nerve Block (Nerve Blocks) 01/2022
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 01/2022
1	Cutaneous Administration 11/2021
1	Palliative Care (Palliative Therapy) 08/2021
1	Topical Administration 01/2021
1	Transplantation 12/2020
1	Decompression 02/2020
1	Microvascular Decompression Surgery 02/2020
1	Traction 01/2019
1	Acupuncture Points (Acupuncture Point) 01/2019